Biotech and Digital Health

Summary Wearable Robotics, a spin-off of Scuola Superiore Sant'Anna, closed a €5 million Series A round led by CDP Venture Capital to expand product portfolio, strengthen regulatory compliance, and boost commercial channels toward key markets, with a particular focus on North America. Key takeaways Wearable Robotics has raised €5 million to boost products, commercial channels, and regulatory compliance, targeting international markets. ALEX RS, a bilateral upper-limb rehabili

Summary Scinus has raised €3 million to accelerate the commercial launch of Osilaris, a closed GMP-compliant bioreactor platform designed for scalable cellular expansion. The round is led by Myosotis Investments and aims to consolidate governance, distribution, and access to advanced therapies across multiple markets. Key takeaways Osilaris is a closed, automated platform designed to expand cells dynamically, reducing contamination risk and minimizing manual handling. The €3M

Summary Tropic has raised €91.3 million in Series C to accelerate the commercialization of bananas and rice developed with gene editing techniques and its GEiGS platform. The funding will finance large-scale production, strengthen supply chains, forge commercial partnerships, and support disease-resistance programs such as TR4. Key takeaways Tropic has closed a €91.3M Series C to scale production and the supply chain and bring gene-edited bananas and rice to export markets. T

In a region renowned for innovation, Eindhoven is emerging as a model of integrating healthcare and AI. AI is entering diagnostic rooms and clinical procedures, but with careful management of privacy and ethics. In this context, digital health Eindhoven AI becomes a framework for assessing opportunities, risks, and the governance needed to turn technological knowledge into tangible results. Catharina Hospital: Cutting-Edge Clinical Hub The Catharina Hospital, built on the out

Engitix, a British biotech focused on the extracellular matrix (ECM) to develop transformative therapies for cancer and fibrosis, has announced the closing of a Series A extension of €21 million. The new capital comes from investors including Netherton Investments, a fund managed on behalf of Mike Platt, co-founder and managing director of BlueCrest Capital Management. This move marks a significant moment in the European biotech landscape, where large-scale ECM data usage and

In a rapidly evolving field like biotechnology, AI for microbiological science is emerging as a driver of innovation capable of accelerating diagnosis, sample analysis, and understanding microbiomes. Spore.Bio, a Paris-based startup, is leading this trend marking a turning point with multimillion-dollar funding from Google.org and with the opening of Spore.Labs, an in-house research division dedicated to AI-native projects for public health and microbiology. The initiative re